| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Sam Chun Dang Pharm. Co. Ltd (KQ: 000250)
000250 Technical Analysis
5
| As on 26th Feb 2026 000250 STOCK Price closed @ 757000.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 174513.30 & Strong Buy for SHORT-TERM with Stoploss of 149585.45 we also expect STOCK to react on Following IMPORTANT LEVELS. |
000250STOCK Price
| Open | 579000.00 | Change | Price | % |
| High | 757000.00 | 1 Day | 174000.00 | 29.85 |
| Low | 574000.00 | 1 Week | 236000.00 | 45.30 |
| Close | 757000.00 | 1 Month | 496500.00 | 190.60 |
| Volume | 838953 | 1 Year | 653400.00 | 630.69 |
| 52 Week High 757000.00 | 52 Week Low 88500.00 | ||||
KQ Korea Most Active Stocks
| 047040 | 10050.00 | 14.86% |
| 047040 | 10050.00 | 14.86% |
| 032980 | 302.00 | 16.15% |
| 007460 | 431.00 | -6.71% |
| 007460 | 431.00 | -6.71% |
| 018880 | 4785.00 | 5.63% |
| 018880 | 4785.00 | 5.63% |
| 036540 | 8340.00 | 16.32% |
| 036540 | 8340.00 | 16.32% |
| 003530 | 8530.00 | 4.02% |
KQ Korea Top Gainers Stocks
KQ Korea Top Losers Stocks
| 000250 Daily Charts |
000250 Intraday Charts |
Whats New @ Bazaartrend |
000250 Free Analysis |
|
|
000250 Important Levels Intraday
| RESISTANCE | 1109641.00 |
| RESISTANCE | 996547.00 |
| RESISTANCE | 926641.00 |
| RESISTANCE | 856735.00 |
| SUPPORT | 657265.00 |
| SUPPORT | 587359.00 |
| SUPPORT | 517453.00 |
| SUPPORT | 404359.00 |
000250 Forecast February 2026
| 4th UP Forecast | 868381 |
| 3rd UP Forecast | 832660 |
| 2nd UP Forecast | 810581 |
| 1st UP Forecast | 788501 |
| 1st DOWN Forecast | 725499 |
| 2nd DOWN Forecast | 703419 |
| 3rd DOWN Forecast | 681340 |
| 4th DOWN Forecast | 645619 |
000250 Weekly Forecast
| 4th UP Forecast | 788217.38 |
| 3rd UP Forecast | 778205.81 |
| 2nd UP Forecast | 772017.38 |
| 1st UP Forecast | 765829.00 |
| 1st DOWN Forecast | 748171.00 |
| 2nd DOWN Forecast | 741982.62 |
| 3rd DOWN Forecast | 735794.19 |
| 4th DOWN Forecast | 725782.62 |
000250 Forecast2026
| 4th UP Forecast | 2045780 |
| 3rd UP Forecast | 1632460 |
| 2nd UP Forecast | 1376980 |
| 1st UP Forecast | 1121500 |
| 1st DOWN Forecast | 392504 |
| 2nd DOWN Forecast | 137022 |
| 3rd DOWN Forecast | -118459 |
| 4th DOWN Forecast | -531778 |
Sam Chun Dang Pharm. Co. Ltd ( KQ Korea Symbol : 000250 )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
000250 Other Details
| Segment | EQ | |
| Market Capital | 1053165355008.00 | |
| Sector | ||
| Industry | ||
| Offical website | > echo $website ; ?> | |
000250 Address
![]() |
||
000250 Latest News
000250 Business Profile
Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea. Address: 351 Hyoryeong-ro, Seoul, South Korea, 06643
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

